Atra stock forecast.

KPRX Stock 12 Months Forecast. $2.75. (347.15% Upside) Based on 2 Wall Street analysts offering 12 month price targets for Kiora Pharmaceuticals in the last 3 months. The average price target is $2.75 with a high forecast of $3.50 and a low forecast of $2.00. The average price target represents a 347.15% change from the last price of $0.62.

Atra stock forecast. Things To Know About Atra stock forecast.

Jun 30, 2023 · ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? According to our current ATRA stock forecast, the value of Atara Biotherapeutics shares will rise by 5.88% and reach $ 1.826488 per share by October 16, 2023. According to our …Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis.Aug 8, 2023 · The percentage change in ATRA’s stock price is not provided. Looking ahead, ATRA’s next reporting date is scheduled for August 9, 2023. Analysts forecast an EPS (earnings per share) of -$0.66 for the current quarter. In the previous year, ATRA reported annual revenue of $63.6 million but incurred a net loss of -$228.3 million.

AT&T Stock Forecast 12-07-2023. Forecast target price for 12-07-2023: $ 16.48. Negative dynamics for AT&T shares will prevail with possible volatility of 1.632%. Pessimistic target level: 16.40. Optimistic target level: 16.67.High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year.Atara Biotherapeutics, Inc. (ATRA) NasdaqGS - NasdaqGS Real Time Price. Currency in USD Follow 2W 10W 9M 0.6478 -0.0122 (-1.85%) At close: 04:00PM EST 0.6223 -0.03 ( …

Nov 22, 2023 · According to the issued ratings of 4 analysts in the last year, the consensus rating for Atara Biotherapeutics stock is Hold based on the current 3 hold ratings and 1 buy rating for ATRA. The average twelve-month price prediction for Atara Biotherapeutics is $28.00 with a high price target of $31.00 and a low price target of $25.00. The consensus price target of analysts on Wall Street is $10.89, which implies an increase of 97.34% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $1.00 and $28.00 respectively. As a result, ATRA is trading at a discount of -9555.17% off the target high and -244.83% off the low.

On average, Wall Street analysts predict that Atara Biotherapeutics 's share price could reach $11.18 by Nov 10, 2024. The average Atara Biotherapeutics stock price …25 Wall Street analysts have issued 1 year price objectives for Pioneer Natural Resources' stock. Their PXD share price targets range from $236.00 to $332.00. On average, they anticipate the company's share price to reach $258.45 in the next twelve months. This suggests a possible upside of 11.3% from the stock's current price.Find the latest Astra Space, Inc. (ASTR) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Performance Outlook. Short Term. 2W - 6W. Mid ...Atara Biotherapeutics Stock Price, News & Analysis (NASDAQ:ATRA) $0.65 -0.01 (-1.52%) (As of 12/1/2023 ET) Compare …The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility ...

Price target. 16.19 0.00 0.00%. The 7 analysts offering 1 year price forecasts for ATRA have a max estimate of — and a min estimate of —.

Atara Biotherapeutics (ATRA) delivered earnings and revenue surprises of -4.62% and 71.48%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?

In this article, we answer “what is sales forecasting?” by breaking down its objectives, owners, methods, and best practices. Sales | What is REVIEWED BY: Jess Pingrey Jess served on the founding team of a successful B2B startup and has use...Stock Price Forecast. The 26 analysts offering 12-month price forecasts for Medtronic PLC have a median target of 89.50, with a high estimate of 104.00 and a low estimate of 68.00. The median ...Nov 13, 2023 · Atara Biotherapeutics stock price predictions for 2022 using artificial intelligence. How much will Atara Biotherapeutics stock be worth in 2022? Target price in 2022. Nov 27, 2023 · Analyst projections state that ATRA is forecast to be at a low of $0.40 and a high of $28.00. In order for the stock price to hit the forecast high, the stock would need to plunge -4207.69% from its current level, while the stock would need to crash 38.46% from its current level to reach the projected low. Tilray Stock Forecast 12-10-2023. Forecast target price for 12-10-2023: $ 1.86. Negative dynamics for Tilray shares will prevail with possible volatility of 11.482%. Pessimistic target level: 1.72. Optimistic target level: 1.94.

Atara Biotherapeutics (NasdaqGS:ATRA) Stock Forecast & Analyst Predictions - Simply Wall St View Valuation Atara Biotherapeutics Future Growth Future …Price Prediction Atara Biotherapeutics price predictions from 2023 to 2027. Gain insights into monthly forecasts, trends, and analyses to make informed investment decisions.Nov 23, 2023 · High Growth Earnings: ATRA is forecast to remain unprofitable over the next 3 years. Revenue vs Market: ATRA's revenue (44.8% per year) is forecast to grow faster than the US market (8.1% per year). High Growth Revenue: ATRA's revenue (44.8% per year) is forecast to grow faster than 20% per year. 11 analysts have issued 12-month price objectives for Air Canada's shares. Their AC share price targets range from C$17.00 to C$42.00. On average, they expect the company's share price to reach C$29.63 in the next twelve months. This suggests a possible upside of 68.2% from the stock's current price.We've seen plenty of personal finance tools designed to help you track what you're spending, but web site PocketSmith is an impressive new web-based personal finance tool with an emphasis on forecasting your financial future. We've seen ple...Their NVDA share price targets range from $195.00 to $780.00. On average, they predict the company's stock price to reach $588.38 in the next year. This suggests a possible upside of 25.8% from the stock's current price. View analysts price targets for NVDA or view top-rated stocks among Wall Street analysts.

The Change in Consensus chart shows the current, 1 week ago, and 1 month ago consensus earnings per share (EPS*) forecasts. For the fiscal quarter endingDec 2022 , the consensus EPS* forecast has ...

Aug 21, 2023 · ATRA stock forecast Our latest prediction for Atara Biotherapeutics Inc's stock price was made on the Aug. 21, 2023 when the stock price was at 1.41$. In the short term (2weeks), ATRA's stock price should underperform the market by -2.71%. During that period the price should oscillate between -13.09% and +13.51%. About. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly voluntary and as a result ... Find the latest Atara Biotherapeutics, Inc. ATRA analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports. Date Range. …All quotes are in local exchange time. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange ...According to 30 stock analysts, the average 12-month stock price forecast for Tesla stock is $238.87, which predicts a decrease of -2.16%. The lowest target is $85 and the highest is $380. On average, analysts rate Tesla stock as a hold.Stock Price Forecast. The 3 analysts offering 12-month price forecasts for Akebia Therapeutics Inc have a median target of 4.00, with a high estimate of 5.00 and a low estimate of 4.00. The median ...ZIM Integrated Shipping Services (NYSE:ZIM) pays an annual dividend of $9.35 per share and currently has a dividend yield of 134.73%. ZIM has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ZIM.

Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts.

TipRanks | Stock Market Research, News and Analyst Forecasts - TipRanks.com

The Gevo stock price gained 1.72% on the last trading day (Friday, 24th Nov 2023), rising from $1.16 to $1.18. During the last trading day the stock fluctuated 4.35% from a day low at $1.15 to a day high of $1.20. The price has risen in 7 of the last 10 days and is up by 11.32% over the past 2 weeks. Volume fell on the last day by -2 million ...Stock Price Forecast. The 2 analysts offering 12-month price forecasts for Mustang Bio Inc have a median target of 16.50, with a high estimate of 25.00 and a low estimate of 8.00. The median ...According to analyst projections, ATRA’s forecast low is $0.50 with $28.00 as the target high. To hit the forecast high, the stock’s price needs a -5500.0% plunge from its current level, while the stock would need to tank 0.0% for it to hit the projected low. Atara Biotherapeutics Inc (ATRA) estimates and forecasts16 analysts have issued twelve-month price objectives for Alibaba Group's shares. Their BABA share price targets range from $90.00 to $150.00. On average, they expect the company's share price to reach $129.20 in the next year. This suggests a possible upside of 74.6% from the stock's current price.Detailed statistics for Atara Biotherapeutics, Inc. (ATRA) stock, including valuation metrics, financial numbers, share information and more. ... Analyst Forecast ...T Stock 12 Months Forecast. Based on 15 Wall Street analysts offering 12 month price targets for AT&T in the last 3 months. The average price target is $19.82 with a high forecast of $28.00 and a low forecast of $16.00. The average price target represents a 26.81% change from the last price of $15.63.ATRA Stock 12 Months Forecast. $5.05. (890.20% Upside) Based on 8 Wall Street analysts offering 12 month price targets for Atara Biotherapeutics in the last 3 months. The average price target is $5.05 with a high forecast of $13.00 and a low forecast of $1.00. The average price target represents a 890.20% change from the last price of $0.51.You may have a lot of questions if you are interested in investing in the stock market for the first time. One question that beginning investors often ask is whether they need a broker to begin trading.

Oct 27, 2023 · Unraveling Atara Biotherapeutics (ATRA) Stock Predictions for 2024 In the dynamic world of stock trading, precise and comprehensive forecasts are crucial. For investors eyeing Atara Biotherapeutics and its promising trajectory, we have meticulously collated insights from various analyst forecasts. Based on short-term price targets offered by 16 analysts, the average price target for Alibaba comes to $126.50. The forecasts range from a low of $100.00 to a high of $150.00. The average price ...34 Wall Street research analysts have issued 12 month price objectives for PayPal's stock. Their PYPL share price targets range from $55.00 to $118.00. On average, they expect the company's share price to reach $78.77 in the next year. This suggests a possible upside of 32.0% from the stock's current price.Instagram:https://instagram. bbby stcokbenefits of starting an llc in delawaretarget walmarthow to purchase oil futures Vroom, Inc. (NASDAQ:VRM) posted its earnings results on Tuesday, November, 7th. The company reported ($0.59) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.41) by $0.18. The company earned $235.63 million during the quarter, compared to analyst estimates of $223.90 million.Analyst projections state that ATRA is forecast to be at a low of $1.40 and a high of $31.00. In order for the stock price to hit the forecast high, the stock would need to plunge -2248.48% from its current level, while the stock would need to crash -6.06% from its current level to reach the projected low. renter's insurance bostonsalesforce forecast ATRA stock forecast for 2023 – 2027. Last updated: January 22, 2023. ATRA. Atara Biotherapeutics, Inc. 3.89 D 9.58% (0.34) Are you interested in Atara Biotherapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the ATRA stock price in 2022-2027. Is ATRA a good long term stock? bank of america stock buy or sell Atara Biotherapeutics stock forecasts are adjusted once a day based on the closing price of the previous trading day. The minimum target price for Atara Biotherapeutics analysts is $ 14.72 . Today 200 Day Moving Average is the resistance level ( 2.335 $).16 equities research analysts have issued twelve-month price targets for SoFi Technologies' stock. Their SOFI share price targets range from $3.00 to $15.00. On average, they anticipate the company's share price to reach $8.78 in the next year. This suggests a possible upside of 12.1% from the stock's current price.Orchid Island Capital (NYSE:ORC) pays an annual dividend of $1.44 per share and currently has a dividend yield of 19.54%. ORC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for ORC.